Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Promote Cell Survival and Induce Actin Filament Remodeling

This publication has 52 references indexed in Scilit:

• The Oncogenic Protein Kinase Tpl-2/Cot Contributes to Epstein-Barr Virus-Encoded Latent Infection Membrane Protein 1-Induced NF-κB Signaling Downstream of TRAF2
  Journal of Virology, 2002
• Regulation of Fas Expression by STAT3 and c-Jun Is Mediated by Phosphatidylinositol 3-Kinase-AKT Signaling
  Journal of Biological Chemistry, 2002
• Epstein-Barr virus: exploiting the immune system
  Nature Reviews Immunology, 2001
• A Positive Regulatory Role for Cbl Family Proteins in Tumor Necrosis Factor-related Activation-induced Cytokine (TRANCE) and CD40L-mediated Akt Activation
  Journal of Biological Chemistry, 2001
• Xid -Like Immunodeficiency in Mice with Disruption of the p85α Subunit of Phosphoinositide 3-Kinase
  Science, 1999
• Polyoma Middle T Antigen Activates the Ser/Thr Kinase Akt in a PI3-Kinase-Dependent Manner
  Biochemical and Biophysical Research Communications, 1998
• Epstein – Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors
  Oncogene, 1997
• Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas
  European Journal Of Cancer, 1995
• Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death
  Cell, 1991
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
  Cell, 1985